Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 3 Sarcopenia 2 Prostatic Neoplasms 2 Multiple Pulmonary Nodules 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Solitary Pulmonary Nodule 1 Solid Tumor, Unspecified, Adult 1 Small Cell Lung Carcinoma 1 Neoplasms 1 Liver Neoplasms 1 Liver Cirrhosis 1 Gallbladder Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Disease 1 Carcinoma, Non-Small-Cell Lung 1 Breast Diseases 1 Anastomotic Leak 1 Acquired Immunodeficiency Syndrome 1

Interventions

Etoposide 23 Cisplatin 15 Carboplatin 13 Irinotecan 12 apatinib 11 anlotinib 10 durvalumab 7 Topotecan 6 toripalimab 4 sintilimab 4 atezolizumab 4 Temozolomide 4 Drug Therapy 4 tislelizumab 3 surufatinib 3 lobaplatin 3 camrelizumab 3 Simvastatin 3 Radiotherapy 3 Ifosfamide 3 Albumin-Bound Paclitaxel 3 pembrolizumab 2 pegylated granulocyte colony-stimulating factor 2 olaparib 2 niraparib 2 isophosphamide mustard 2 avelumab 2 X-Rays 2 Platinum 2 Nivolumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Small Cell Lung Carcinoma × Tomography, X-Ray Computed × Clear all

NCT02738346 2016-04-25

CBPC

University Hospital, Angers

Phase 3 Unknown

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡